Wellcome Leap: "In Utero: Measurement and Modelling during Gestational Development"

A Wellcome Leap lançou uma nova chamada destinada à criação de meios para mensurar, modelar e prever o desenvolvimento gestacional com precisão suficiente para reduzir pela metade as taxas de óbitos fetais. O valor total da chamada é de US$ 50 milhões e os abstracts devem ser submetidos até 30 de junho.
Por: Wellcome Leap.
Acesse aqui a matéria original.


Every 16 seconds one baby is stillborn. That amounts to more than two million stillborn babies globally every year. Stillbirths have long-lasting personal and psychological consequences for parents, as well as substantial costs for wider society.
 
“Experiencing a stillbirth during pregnancy or childbirth is a tragedy insufficiently addressed in global agendas, policies and funded programmes. There are psychological costs to women, especially women, and their families, such as maternal depression, financial consequences and economic percussions, as well as stigma and taboo.”
 
– World Health Organization
The internationally recognised classification of a stillbirth is a baby who dies after 28 weeks of pregnancy, but before or during birth
Early recognition of emerging complications in utero, coupled with timely and safe delivery, is estimated to have the potential to reduce the number of stillborn babies by half. Yet progress to reduce stillbirth remains stubbornly slow. In sub-Saharan Africa headway in reducing stillbirth rates has been outpaced by growth in the total number of births, so stillbirth numbers are actually rising. In the USA stillbirth rates have been static for more than a decade, which amounts to a total of 12,000 stillborn babies each year. Every child’s death is heartbreaking, and this number of stillbirths is ten times higher than the annual number of deaths from childhood cancer. Saiba mais...

Desenvolvido por IFUSP